Frontiers in Immunology | |
Diagnostic and Predictive Contribution of Autoantibodies Screening in a Large Series of Patients With Primary Immunodeficiencies | |
Abdalbasset Ketfi1  Hassen Messaoudi2  Nadia Boukhenfouf3  Mohamed Amine Ifri4  Tahar Bencharif Madani5  Hayet Belhadj6  Keltoum Nafissa Benhala7  Mokhtar Khiari7  Nacera Cherif8  Leila Smati9  Sihem Taguemount1,10  Kamel Djenouhat1,10  Asma Oukil1,10  Asma Soufane1,10  Hamza Iguerguesdaoune1,10  Azzeddine Tahiat1,10  Chahinez Boubidi1,11  Zoulikha Zeroual1,11  Zakia Arada1,12  Warda Drali1,12  Djamila Bouziane1,13  Ouardia Ibsaine1,13  Zair Bouzerar1,14  Souhila Melzi1,14  Laziz Atek1,15  Samira Aggoune1,15  Hachemi Maouche1,15  Chafa Bendahmane1,16  Reda Belbouab1,17  Mohamed Samir Ladj1,17  Rachida Boukari1,17  Abdelghani Yagoubi1,18  | |
[1] 0Department of Pneumology, Rouiba Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;1Department of Internal Medicine, Mustapha University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;2Department of Pediatrics, Rouiba Hospital, Algiers, Algeria;3Department of Pediatrics, Thenia Hospital, Boumerdes, Algeria;4Department of Pediatrics, Mansourah Hospital, Constantine, Algeria;5Department of Pediatrics, Central Hospital of the Army, Algiers, Algeria;6Department of Pediatrics A, Beni Messous University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;7Department of Pediatrics B, Beni Messous University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;8Department of Pediatrics, Bologhine Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Medical Biology, Rouiba Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics A, Hussein Dey University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics B, Hussein Dey University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics, Ain Taya Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics, Bab El-Oued University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics, El-Harrach Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Department of Pediatrics, Meftah Hospital, Blida, Algeria;Department of Pediatrics, Mustapha University Hospital, Algiers Faculty of Medicine, University of Algiers 1, Algiers, Algeria;Pediatric Gastroenterology, Centre Algérois de Pédiatrie, Algiers, Algeria; | |
关键词: primary immunodeficiencies; autoantibody; screening; autoimmune cytopenia; celiac disease; platelet-bound IgM; | |
DOI : 10.3389/fimmu.2021.665322 | |
来源: DOAJ |
【 摘 要 】
ObjectivesTo evaluate the diagnostic and predictive contribution of autoantibodies screening in patients with primary immunodeficiencies (PIDs).MethodsIn the present study, PID patients and healthy controls have been screened for 54 different autoantibodies. The results of autoantibodies screening in PID patients were correlated to the presence of autoimmune diseases.ResultsA total of 299 PID patients were included in this study with a predominance of antibody deficiencies (27.8%) followed by immunodeficiencies affecting cellular and humoral immunity (26.1%) and complement deficiencies (22.7%). Autoimmune manifestations were present in 82 (27.4%) patients. Autoimmune cytopenia (10.4%) was the most common autoimmune disease followed by gastrointestinal disorders (10.0%), rheumatologic diseases (3.7%), and endocrine disorders (3.3%). Autoantibodies were found in 32.4% of PID patients and 15.8% of healthy controls (P < 0.0005). Anti-nuclear antibodies (ANA) (10.0%), transglutaminase antibody (TGA) (8.4%), RBC antibodies (6.7%), anti-smooth muscle antibody (ASMA) (5.4%), and ASCA (5.0%) were the most common autoantibodies in our series. Sixty-seven out of the 82 patients with autoimmune manifestations (81.7%) were positive for one or more autoantibodies. Eleven out of the 14 patients (78.6%) with immune thrombocytopenia had positive platelet-bound IgM. The frequencies of ASCA and ANCA among patients with IBD were 47.4% and 21.0% respectively. All patients with celiac disease had TGA-IgA, while six out of the 11 patients with rheumatologic diseases had ANA (54.5%). Almost one third of patients (30/97) with positive autoantibodies had no autoimmune manifestations. ANA, rheumatoid factor, ASMA, anti-phospholipid antibodies and ANCA were often detected while specific AID was absent. Despite the low positive predictive value of TGA-IgA and ASCA for celiac disease and inflammatory bowel disease respectively, screening for these antibodies identified undiagnosed disease in four patients with positive TGA-IgA and two others with positive ASCA.ConclusionThe present study provides valuable information about the frequency and the diagnostic/predictive value of a large panel of autoantibodies in PIDs. Given the frequent association of some AIDs with certain PIDs, screening for corresponding autoantibodies would be recommended. However, positivity for autoantibodies should be interpreted with caution in patients with PIDs due to their low positive predictive value.
【 授权许可】
Unknown